Acute lymphoblastic leukemia diagnostic study of choice: Difference between revisions
Shyam Patel (talk | contribs) (Created page with "__NOTOC__ {{Acute lymphoblastic leukemia}} {{CMG}} {{shyam}} ==Overview== The diagnostic study of choice for acute lymphoblastic lymphoma is bone marrow biopsy. ==Diagnostic...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Acute lymphoblastic leukemia}} | {{Acute lymphoblastic leukemia}} | ||
{{CMG}} {{shyam}} | {{CMG}}, {{shyam}} | ||
==Overview== | ==Overview== | ||
Revision as of 21:20, 27 December 2018
|
Acute lymphoblastic leukemia Microchapters |
|
Differentiating Acute lymphoblastic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acute lymphoblastic leukemia diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Acute lymphoblastic leukemia diagnostic study of choice |
|
FDA on Acute lymphoblastic leukemia diagnostic study of choice |
|
CDC on Acute lymphoblastic leukemia diagnostic study of choice |
|
Acute lymphoblastic leukemia diagnostic study of choice in the news |
|
Blogs on Acute lymphoblastic leukemia diagnostic study of choice |
|
Directions to Hospitals Treating Acute lymphoblastic leukemia |
|
Risk calculators and risk factors for Acute lymphoblastic leukemia diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Shyam Patel [2]
Overview
The diagnostic study of choice for acute lymphoblastic lymphoma is bone marrow biopsy.
Diagnostic study of choice
The diagnostic study of choice for acute lymphoblastic lymphoma is bone marrow biopsy. A bone marrow biopsy must show 20% or greater blasts of lymphoid immunophenotype. This diagnostic criteria is very similar to that of acute myeloid leukemia.[1]
References
- ↑ Terwilliger T, Abdul-Hay M (2017). "Acute lymphoblastic leukemia: a comprehensive review and 2017 update". Blood Cancer J. 7 (6): e577. doi:10.1038/bcj.2017.53. PMC 5520400. PMID 28665419.